Prescription
Semaglutide
FDA-approved semaglutide products are prescribed for specific indications, including type 2 diabetes or chronic we...
View optionClear Stream Health
Research OnlyRetatrutide
Investigational triple-receptor agonist
Retatrutide is investigational and is not FDA-approved. FDA states that it cannot be used in compounding under federal law; this listing is educational and does not represent treatment availability.
Treatment details
What’s included
Educational information and discussion of approved alternatives with a licensed clinician.
Clinical & Availability Review
Office: 2874 Route 94, Washingtonville, NY 10992
Appointments
Monday through Saturday from 1:00 PM to 6:00 PM.
Mobile infusion appointments are available Monday through Saturday from 9:00 AM to 8:00 PM.
This item is listed for education. It is not represented as an available or FDA-approved treatment.
Explore more
Related peptide options
Prescription
Prescription
Tirzepatide
FDA-approved tirzepatide products may be prescribed for specific diabetes or chronic weight-management indications...
View option